177 related articles for article (PubMed ID: 15620391)
21. A double-blind, placebo-controlled study of the impact of galantamine on anterograde memory impairment during electroconvulsive therapy.
Matthews JD; Siefert CJ; Blais MA; Park LT; Siefert CJ; Welch CA; Dubois CM; van Nieuwenhuizen AO; Rooney KO; Seabrook RC; Durham LE; Adams HC; Fava M
J ECT; 2013 Sep; 29(3):170-8. PubMed ID: 23519225
[TBL] [Abstract][Full Text] [Related]
22. Randomized comparison of ultra-brief bifrontal and unilateral electroconvulsive therapy for major depression: clinical efficacy.
Sienaert P; Vansteelandt K; Demyttenaere K; Peuskens J
J Affect Disord; 2009 Jul; 116(1-2):106-12. PubMed ID: 19081638
[TBL] [Abstract][Full Text] [Related]
23. Cognition in elderly patients receiving unilateral and bilateral electroconvulsive therapy: a prospective, naturalistic comparison.
O'Connor DW; Gardner B; Eppingstall B; Tofler D
J Affect Disord; 2010 Aug; 124(3):235-40. PubMed ID: 20053457
[TBL] [Abstract][Full Text] [Related]
24. Long-term follow-up after successful electroconvulsive therapy for depression: a 4- to 8-year naturalistic follow-up study.
van Beusekom BS; van den Broek WW; Birkenhäger TK
J ECT; 2007 Mar; 23(1):17-20. PubMed ID: 17435567
[TBL] [Abstract][Full Text] [Related]
25. Response to ECT in bipolar I, bipolar II and unipolar depression.
Medda P; Perugi G; Zanello S; Ciuffa M; Cassano GB
J Affect Disord; 2009 Nov; 118(1-3):55-9. PubMed ID: 19223079
[TBL] [Abstract][Full Text] [Related]
26. Effectiveness and pattern of use of continuation and maintenance electroconvulsive therapy.
Martínez-Amorós E; Cardoner N; Gálvez V; Urretavizcaya M
Rev Psiquiatr Salud Ment; 2012; 5(4):241-53. PubMed ID: 23021297
[TBL] [Abstract][Full Text] [Related]
27. The efficacy of ultrabrief-pulse (0.25 millisecond) versus brief-pulse (0.50 millisecond) bilateral electroconvulsive therapy in major depression.
Niemantsverdriet L; Birkenhäger TK; van den Broek WW
J ECT; 2011 Mar; 27(1):55-8. PubMed ID: 21343712
[TBL] [Abstract][Full Text] [Related]
28. Does comorbid alcohol and substance abuse affect electroconvulsive therapy outcome in the treatment of mood disorders?
Moss L; Vaidya N
J ECT; 2014 Mar; 30(1):22-5. PubMed ID: 23859979
[TBL] [Abstract][Full Text] [Related]
29. Electroconvulsive therapy in pregnant patients.
Bulbul F; Copoglu US; Alpak G; Unal A; Demir B; Tastan MF; Savas HA
Gen Hosp Psychiatry; 2013; 35(6):636-9. PubMed ID: 23890597
[TBL] [Abstract][Full Text] [Related]
30. Effects of propofol and ketamine as combined anesthesia for electroconvulsive therapy in patients with depressive disorder.
Wang X; Chen Y; Zhou X; Liu F; Zhang T; Zhang C
J ECT; 2012 Jun; 28(2):128-32. PubMed ID: 22622291
[TBL] [Abstract][Full Text] [Related]
31. [Working memory disturbances in patients with major depression after ECT treatment].
Datka W; Siwek M; Dudek D; Maczka G; Zieba A
Psychiatr Pol; 2007; 41(3):339-49. PubMed ID: 17900050
[TBL] [Abstract][Full Text] [Related]
32. Relative ineffectiveness of ultrabrief right unilateral versus bilateral electroconvulsive therapy in depression.
McCormick LM; Brumm MC; Benede AK; Lewis JL
J ECT; 2009 Dec; 25(4):238-42. PubMed ID: 19384251
[TBL] [Abstract][Full Text] [Related]
33. Acute electroconvulsive therapy followed by maintenance electroconvulsive therapy decreases hospital re-admission rates of older patients with severe mental illness.
Shelef A; Mazeh D; Berger U; Baruch Y; Barak Y
J ECT; 2015 Jun; 31(2):125-8. PubMed ID: 25373561
[TBL] [Abstract][Full Text] [Related]
34. Electroconvulsive therapy for comorbid major depressive disorder and posttraumatic stress disorder.
Watts BV
J ECT; 2007 Jun; 23(2):93-5. PubMed ID: 17548978
[TBL] [Abstract][Full Text] [Related]
35. Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients.
Bocchio-Chiavetto L; Zanardini R; Bortolomasi M; Abate M; Segala M; Giacopuzzi M; Riva MA; Marchina E; Pasqualetti P; Perez J; Gennarelli M
Eur Neuropsychopharmacol; 2006 Dec; 16(8):620-4. PubMed ID: 16757154
[TBL] [Abstract][Full Text] [Related]
36. Propofol and methohexital as anesthetic agents for electroconvulsive therapy: a randomized, double-blind comparison of electroconvulsive therapy seizure quality, therapeutic efficacy, and cognitive performance.
Geretsegger C; Nickel M; Judendorfer B; Rochowanski E; Novak E; Aichhorn W
J ECT; 2007 Dec; 23(4):239-43. PubMed ID: 18090696
[TBL] [Abstract][Full Text] [Related]
37. Naturalistic comparative study of outcome and cognitive effects of unmodified electro-convulsive therapy in schizophrenia, mania and severe depression in Nigeria.
Ikeji OC; Ohaeri JU; Osahon RO; Agidee RO
East Afr Med J; 1999 Nov; 76(11):644-50. PubMed ID: 10734527
[TBL] [Abstract][Full Text] [Related]
38. Electroconvulsive therapy and resistant depression: clinical implications of seizure threshold.
Shapira B; Lidsky D; Gorfine M; Lerer B
J Clin Psychiatry; 1996 Jan; 57(1):32-8. PubMed ID: 8543545
[TBL] [Abstract][Full Text] [Related]
39. Rehospitalization rate after continued electroconvulsive therapy--a retrospective chart review of patients with severe depression.
Nordenskjöld A; von Knorring L; Engström I
Nord J Psychiatry; 2011 Feb; 65(1):26-31. PubMed ID: 20482461
[TBL] [Abstract][Full Text] [Related]
40. Individualized continuation electroconvulsive therapy and medication as a bridge to relapse prevention after an index course of electroconvulsive therapy in severe mood disorders: a naturalistic 3-year cohort study.
Odeberg H; Rodriguez-Silva B; Salander P; Mårtensson B
J ECT; 2008 Sep; 24(3):183-90. PubMed ID: 18695624
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
